Note: Ingredients listed on restricted chemical lists
EC/CAS
1314-13-2
Name of the chemical
Zinc oxide; C.I. 77947
Concentration
0.5-1.5
General Information
Version
3
Revision date
2026-07-13
Product name
GLIDDEN ROOF COATING ROJO CAM
1.2.1 Relevant identified uses
Consumer applications
Manufacturer Name
PPG Industries Panama Inc
Emergency telephone
1-800-441-9695
Icons in SDS
Company Information
company name
PPG Industries Panama Inc
GHS Information
Signal word
No signal word
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
28% (oral), 35% (dermal), 50.9% (inhalation)
Signal word
No signal word.
Hazard statements
No known significant effects or critical hazards.
Precautionary statements
General : Read carefully and follow all instructions. Keep out of reach of children. If medical advice is needed, have product container or label at hand.
Prevention
Not applicable.
Response
Not applicable.
Storage
Not applicable.
Disposal
Not applicable.
Supplemental label elements
Contains isothiazolinones. May cause allergic reaction. Sanding and grinding dusts may be harmful if inhaled. Emits toxic fumes when heated. Hazards identified when used : Photosensitive agents : In case of accidental eye contact, avoid direct exposure to the sun or other sources of UV light as severe irritation including burns may result. These reactions can be delayed – get medical attention if pain, irritation or blistering occurs after contact. In case of accidental skin contact, avoid direct exposure to the sun or other sources of UV light as severe irritation including burns may result. These reactions can be delayed – get medical attention if pain, irritation, rash or blistering occurs after contact.
2.3 Other hazards
None known.
2.1 Classification of the substance or mixture
Not classified. substance or mixture Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 28% (oral), 35% (dermal), 50.9% (inhalation)
